Advertisement
Research Article

Relationship between Obstructive Sleep Apnea Severity and Sleep, Depression and Anxiety Symptoms in Newly-Diagnosed Patients

  • Paul M. Macey mail,

    pmacey@ucla.edu

    Affiliations: School of Nursing, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, United States of America, Brain Research Institute, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Mary A. Woo,

    Affiliation: School of Nursing, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Rajesh Kumar,

    Affiliation: Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Rebecca L. Cross,

    Affiliation: School of Nursing, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Ronald M. Harper

    Affiliations: Brain Research Institute, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, United States of America, Department of Neurobiology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, United States of America

    X
  • Published: April 16, 2010
  • DOI: 10.1371/journal.pone.0010211

Abstract

Obstructive sleep apnea (OSA) occurs in at least 10% of the population, and leads to higher morbidity and mortality; however, relationships between OSA severity and sleep or psychological symptoms are unclear. Existing studies include samples with wide-ranging comorbidities, so we assessed relationships between severity of OSA and common sleep and psychological disturbances in recently diagnosed OSA patients with minimal co-morbidities. We studied 49 newly diagnosed, untreated OSA patients without major co-morbidities such as mental illness, cardiovascular disease, or stroke; subjects were not using psychoactive medications or tobacco (mean ± std age: 46.8±9.1 years; apnea/hyponea index [AHI]: 32.1±20.5 events/hour; female/male: 12/37; weight <125 kg). We evaluated relationships between the AHI and daytime sleepiness (Epworth Sleepiness Scale; ESS), sleep quality (Pittsburg Sleep Quality Index; PSQI), depressive symptoms (Beck Depression Inventory-II; BDI), and anxiety symptoms (Beck Anxiety Inventory; BAI), as well as sex and body mass index (BMI). AHI was similar in females and males. Mean levels of all symptoms were above normal thresholds, but AHI was not correlated with age, ESS, PSQI, BDI, or BAI; only BMI was correlated with OSA severity. No differences in mean AHI appeared when subjects were grouped by normal versus elevated values of ESS, PSQI, BDI, or BAI. Consistent with other studies, a strong link between OSA severity and psychological symptoms did not appear in these newly diagnosed patients, suggesting that mechanisms additional to the number and frequency of hypoxic events and arousals occurring with apneas contribute to adverse health effects in OSA. OSA patients presenting with mild or moderate severity, and no major co-morbidities will not necessarily have low levels of sleep or psychological disturbances.

Introduction

Obstructive sleep apnea (OSA) occurs in approximately 10% of the population, leads to physical and psychological co-morbidities, and is associated with higher all-cause mortality [1], [2], [3], [4]. Symptoms of OSA include daytime sleepiness, poor sleep quality, and co-morbidities such as high levels of depressive symptoms and anxiety [5], [6], [7], but the relationship between OSA severity and accompanying symptoms is weak. The severity of OSA, as defined by the American Academy of Sleep Medicine [4], is classified by the number of partial or complete cessations of breathing per hour during sleep, the apnea/hypopnea index (AHI). However, most studies do not report strong relationships between AHI and severity of symptoms [8], [9]. The extent to which a patient's reported AHI level predicts severity of symptoms remains unclear, and is the topic of recent investigations [10], [11], [12], [13].

Excessive daytime sleepiness is the most common symptom associated with OSA [4], [6]. High daytime sleepiness is often a primary reason for referring a person for a polysomnographic study, and the evidence of higher measures of daytime sleepiness in OSA is unequivocal [4], [6]. Since OSA is defined according to a cut-off in AHI, a logical assumption is that higher AHI leads to higher daytime sleepiness. However, while some large samples show a statistically significant correlation, AHI and daytime sleepiness measures are not strongly correlated [9], [13], [14], [15], [16], [17], a pattern noted in the revised International Classifications of Sleep Disorders criteria [18].

Other symptoms that are present in persons with OSA also show only weak relationships with AHI. Poor sleep quality is common in people with OSA, but is not explained by AHI [19], even though obstructive events are typically associated with arousals. Apneic indices fail to explain other characteristics: levels of depressive symptoms, while high in approximately half of OSA patients [5], [20], [21], [22], correlate at best poorly with AHI [10], [23], and similar findings are true for anxiety symptoms [24], [25], [26]. Mood and affect disturbances could arise from neural injury that occurs in the condition [27], [28], [29], [30], and such injury would be expected to be greater with increasing severity, since animal evidence shows that repeated hypoxic episodes lead to cellular injury and death in a dose-dependent fashion [31], [32], [33], [34].

Existing studies mostly describe typical OSA populations that include patients with major risk factors for illness and co-morbidities, such as severe obesity, tobacco use, mental disorders, and major cardiovascular disease. Since these factors influence sleep and affective symptoms, it is possible that a stronger relationship between OSA severity and symptoms will be present in a sample of patients without major health issues other than OSA. Therefore, our objective was to describe relationships between severity of OSA and severity of common sleep and psychological disturbances present in the sleep disorder, in a sample with minimal co-morbidities. We studied recently-diagnosed, moderate to severe OSA patients with minimal comorbidities, who had not started treatment, and who did not have other major cardiovascular or psychiatric disorders.

Methods

All procedures were approved by the UCLA Institutional Review Board, and all participants provided written, informed consent.

We performed a cross-sectional study of OSA patients, diagnosed based on an overnight sleep study, who completed commonly-used questionnaires for evaluation of sleep and psychological symptoms.

Subjects

We studied 49 newly diagnosed, untreated OSA patients without major comorbidities (Table 1). Subjects were recruited via the UCLA Sleep Disorders Laboratory. Patients were untreated for the sleep disorder, did not currently smoke, and were not taking psychiatric medications. Screening was by self-report on initial clinical interview prior to study onset. These subjects were originally recruited as part of a brain imaging study [28], so inclusion criteria due to scanner limitations included a weight of less than 125 kg, no claustrophobia, and absence of metallic implants.

thumbnail

Table 1. Subject information.

doi:10.1371/journal.pone.0010211.t001

Data Collection

The OSA severity was determined based on an overnight sleep study. The AHI, or number of apnea/hypopnea per hour, was determined according to standard criteria [4].

We collected subject characteristics of age, sex and body mass index (BMI), as well as measures of sleep, depression and anxiety symptoms. All symptoms were assessed with commonly-used self-report questionnaires. Daytime sleepiness was measured with the Epworth Sleepiness Scale (ESS), sleep quality by the Pittsburgh Sleep Quality Index (PSQI), depressive symptoms with the Beck Depression Inventory II (BDI), and anxiety symptoms with the Beck Anxiety Inventory (BAI). These measures show moderate to strong validity and reliability in healthy people and in groups with medical conditions [35], [36], [37], [38], [39], although OSA populations have not been assessed.

Statistical analysis

The non-parametric Spearman's rho was calculated for AHI correlations with ESS, PSQI, BDI, BAI and BMI. Mean AHI values were compared between groups that were defined by classifying subjects into normal and elevated symptom levels, using independent samples t-tests. The standard p threshold of 0.05 was used. The 95% confidence intervals for Spearman's rho were calculated using a bootstrap method (500 samples). Correlations and independent samples t-tests were performed with the statistical software SPSS (Chicago, IL), and the confidence intervals were calculated with the bootstrap function in MATLAB 7.8 with the Statistics Toolbox (The Mathworks Inc., Natwick, MA). Power analyses were performed with G*Power 3 [40].

Results

Main Findings

The AHI, the “gold standard” of obstructive sleep apnea severity, was not significantly correlated with symptoms of daytime sleepiness, sleep quality, depression, or anxiety. Specifically, AHI showed no significant correlations with age, ESS, PSQI, BDI, or BAI (Table 2, 1st column). Only BMI showed a significant positive correlation with AHI. Additionally, we found no group differences in mean AHI when subjects were categorized into two groups according to normal/elevated measures of each of ESS, PSQI, BDI, or BAI (Table 3). We used a cutoff of >9 to classify BDI measures as high, a threshold lower than the typical 14, but a more sensitive level [41], which we previously showed can predict additional neural injury in high relative to low BDI OSA patients [42]. The full correlation table showed additional significant relationships between all combinations of BDI, BAI and PSQI (Table 2).

thumbnail

Table 2. Correlations.

doi:10.1371/journal.pone.0010211.t002
thumbnail

Table 3. Mean comparisons.

doi:10.1371/journal.pone.0010211.t003

Power Analysis

A medium-to-large effect size, measured as Pearson's r, of 0.38 (0.34 one-tailed) would be required to detect any relationship with 80% power at α = 0.05 [40]. The largest symptom and AHI correlation effect size (non-parametric equivalent) found in this sample was 0.18 (Table 2, 1st column).

Discussion

A strong link between the standard measure of OSA severity, the AHI, and accompanying symptoms did not appear in these newly-diagnosed patients, who were untreated and without major co-morbid illness. However, the presence of OSA, diagnosed primarily based on AHI values, was associated with abnormally high levels of depressive and anxious symptoms, daytime sleepiness, and poor sleep quality. These findings suggest that mechanisms other than the number and frequency of hypoxic events contribute to adverse health effects in this patient population.

As found in other OSA populations [11], [43], levels of daytime sleepiness, poor sleep quality, depression and anxiety were high, with mean levels of these symptoms above normal cutoff thresholds (Table 3). Thus, the absence of correlation between symptoms and disease severity does not result from low levels of symptoms in this set of OSA patients. One possibility is that the population consists of several distinct subgroups, which are affected differently by the apneic periods. Variations in affective and mood symptoms in particular are likely to be associated with variations in a number of symptoms related to neural functioning, as we previously showed that, in subsets of the present 49 OSA patients, depressive symptoms are associated with brain structural changes, as are symptoms of anxiety [42], [44]. Our neuroimaging findings show differential effects on brain structure of diabetes, sleep state in which apneas occur, and sex [45], [46], [47]. The heterogeneous nature of characteristics associated with brain changes in OSA suggests that these variables should be considered separately with regards to their influence on sleep and psychological symptoms; the present study did not have enough subjects to power such tests.

The findings support the hypothesis that AHI is not the most appropriate polysomnographic measure of clinical impact of OSA, a relationship noted previously [48], [49]. One possible reason is that AHI is based on numbers of all apneas and hypopneas, but not severity of apneic events. Symptoms like poor sleep quality and daytime sleepiness may be more closely related to number and extent of arousals, which are principally associated with obstructive apneas. The frequency of arousals is a better predictor of fatigue [8], another common symptom of OSA [50]. Similarly, blood oxygen desaturation appears to be a better predictor than AHI of daytime sleepiness [51] and cardiovascular sequelae [52], [53]. The problem of defining clinically-relevant operational definitions of sleep variables was part of the motivation for the development by the American Academy of Sleep Medicine of new scoring criteria in 2007 [54], although it is unclear whether the new definitions of severity are better predictors of symptoms.

The lack of strong correlations between AHI and subjective sleep symptoms suggests that factors other than respiratory events and arousal contribute to these disturbances. Affective disruptions appear to be closely related to sleep quality: the PSQI had the strongest correlations with the BDI and BAI, similar to a previous report [25]. While self-reports are potentially inaccurate, especially in psychologically disturbed populations, the PSQI has moderate to high validity and reliability [35], with validation in other sleep-disturbed populations [55].

Determining the extent to which mood disruptions are independent of OSA is problematic, since several mental illnesses, including depression, are classified by symptoms that include sleep disturbances [56]. The BDI includes questions on symptoms that overlap typical OSA characteristics, such as sleepiness and fatigue, loss of libido, and impaired concentration. This overlap does not alter the depressive symptoms themselves but confounds interpretation of the source of the mood disturbances; we cannot disentangle the extent to which individuals with depressed mood experience a disorder independent of OSA. The DSM-IV criteria for organic rule-out of a primary mood disorder, i.e., diagnosis of a mood disorder that is secondary to a physical medical illness [57], do not clarify whether depressed mood in OSA should be considered secondary to the physical disorder. Our earlier work demonstrating that mildly depressed or anxious OSA subjects show greater brain injury over patients with normal mood or affect suggests a neural basis for the mood disturbances [42], [44]. However, whether OSA preceded the neural injury and mood symptoms cannot be determined in the present cross-sectional study.

Limitations of the current study include the specific nature of the study population; a group with minimal co-morbidities, recent diagnosis, and limited BMI is not representative of the general OSA population. Furthermore, the heterogenous nature of the disorder, even within the restricted sample used here, means that a much larger number of subjects than 49 would need to be studied to verify that the findings generalize to a larger population. Additional limitations relate to the lack of objective measures of symptoms. However, the variables assessed in the present study reflect information typically available to, or easily collected by clinicians. More-accurate measurements may allow relationships between OSA severity and symptoms to be detected, but given the minimal effects found in this and other studies, it is unlikely that any strong correlation would appear using different measures. Other potential approaches to refining the analysis include increasing the number of subjects, or selecting a different OSA population. In particular, a possibility would be to study separate populations based on depression, sex, or sleep quality, to potentially elucidate relationships within those subgroups.

Clinical Implications

A patient's reported OSA severity should not be assumed to directly relate to severity of accompanying psychological symptoms. These findings do not negate the importance of sleep-disordered breathing; many clinical symptoms are associated with sleep disturbances, and screening for the presence of sleep disorders, including OSA, is important [58]. The present results are limited to newly-diagnosed, untreated, middle-aged OSA patients without major co-morbid illness, and weighing less than 125 kg, so different patterns may appear in other OSA populations. Obesity (measured as BMI), a known risk factor for the sleep disorder, is associated with OSA severity, as is the most prominent co-morbidity, hypertension [12], [59]. For patients who have received a sleep study, the presence of OSA of any severity would suggest that a patient likely has abnormally high levels of daytime sleepiness, depression, and anxiety, as well as poor sleep quality. For patients without an assessment for OSA, but presenting with sleepiness, depression, and complaints of poor sleep, the presence of OSA may be suspected, but the level of symptoms should not be assumed to relate to the severity of the sleep disorder.

Author Contributions

Conceived and designed the experiments: PMM MAW RLC RMH. Performed the experiments: PMM MAW RK RLC RMH. Analyzed the data: PMM MAW RK. Contributed reagents/materials/analysis tools: PMM MAW. Wrote the paper: PMM MAW RK RLC RMH.

References

  1. 1. Marshall NS, Won KKH, Liu PY, Cullen SRJ, Knuiman MW, et al. (2008) Sleep Apnea as an Independent Risk Factor for All-Cause Mortality: The Busselton Health Study. Sleep 31: 1079–1085.
  2. 2. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, et al. (2008) Sleep Disordered Breathing and Mortality: Eighteen-Year Follow-up of the Wisconsin Sleep Cohort. Sleep and Biological Rhythms 31: 1071–1078.
  3. 3. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, et al. (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163: 19–25.
  4. 4. (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22: 667–689.
  5. 5. Reynolds CF 3rd, Kupfer DJ, McEachran AB, Taska LS, Sewitch DE, et al. (1984) Depressive psychopathology in male sleep apneics. J Clin Psychiatry 45: 287–290.
  6. 6. Seneviratne U, Puvanendran K (2004) Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors. Sleep Med 5: 339–343.
  7. 7. Baldwin CM, Griffith KA, Nieto FJ, O'Connor GT, Walsleben JA, et al. (2001) The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 24: 96–105.
  8. 8. Yue HJ, Bardwell W, Ancoli-Israel S, Loredo JS, Dimsdale JE (2009) Arousal frequency is associated with increased fatigue in obstructive sleep apnea. Sleep Breath.
  9. 9. Johansson P, Alehagen U, Svanborg E, Dahlstrom U, Brostrom A (2009) Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness. Sleep Med 10: 1005–1011.
  10. 10. Dominici M, Gomes Mda M (2009) Obstructive sleep apnea (OSA) and depressive symptoms. Arq Neuropsiquiatr 67: 35–39.
  11. 11. Ronksley PE, Hemmelgarn BR, Heitman SJ, Hanly PJ, Faris PD, et al. (2009) Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 64: 834–839.
  12. 12. Thong JF, Pang KP (2008) Clinical parameters in obstructive sleep apnea: are there any correlations? J Otolaryngol Head Neck Surg 37: 894–900.
  13. 13. Koutsourelakis I, Perraki E, Bonakis A, Vagiakis E, Roussos C, et al. (2008) Determinants of subjective sleepiness in suspected obstructive sleep apnoea. J Sleep Res 17: 437–443.
  14. 14. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, et al. (2005) Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 90: 4510–4515.
  15. 15. Sauter C, Asenbaum S, Popovic R, Bauer H, Lamm C, et al. (2000) Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndrome. J Sleep Res 9: 293–301.
  16. 16. Roure N, Gomez S, Mediano O, Duran J, Pena Mde L, et al. (2008) Daytime sleepiness and polysomnography in obstructive sleep apnea patients. Sleep Med 9: 727–731.
  17. 17. Duran J, Esnaola S, Rubio R, Iztueta A (2001) Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 163: 685–689.
  18. 18. American Academy of Sleep Medicine (2005) International classification of sleep disorders: Diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine.
  19. 19. Kezirian EJ, Harrison SL, Ancoli-Israel S, Redline S, Ensrud K, et al. (2009) Behavioral correlates of sleep-disordered breathing in older men. Sleep 32: 253–261.
  20. 20. Millman RP, Fogel BS, McNamara ME, Carlisle CC (1989) Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry 50: 348–351.
  21. 21. Akashiba T, Kawahara S, Akahoshi T, Omori C, Saito O, et al. (2002) Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest 122: 861–865.
  22. 22. Vandeputte M, de Weerd A (2003) Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med 4: 343–345.
  23. 23. McCall WV, Harding D, O'Donovan C (2006) Correlates of Depressive Symptoms in Patients With Obstructive Sleep Apnea. J Clin Sleep Med 2:
  24. 24. Borak J, Cieslicki JK, Koziej M, Matuszewski A, Zielinski J (1996) Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J Sleep Res 5: 123–127.
  25. 25. Naismith S, Winter V, Gotsopoulos H, Hickie I, Cistulli P (2004) Neurobehavioral functioning in obstructive sleep apnea: differential effects of sleep quality, hypoxemia and subjective sleepiness. J Clin Exp Neuropsychol 26: 43–54.
  26. 26. Saunamaki T, Jehkonen M (2007) Depression and anxiety in obstructive sleep apnea syndrome: a review. Acta Neurol Scand 116: 277–288.
  27. 27. Macey PM, Henderson LA, Macey KE, Alger JR, Frysinger RC, et al. (2002) Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med 166: 1382–1387.
  28. 28. Macey PM, Kumar R, Woo MA, Valladares EM, Yan-Go FL, et al. (2008) Brain structural changes in obstructive sleep apnea. Sleep 31: 967–977.
  29. 29. Yaouhi K, Bertran F, Clochon P, Mezenge F, Denise P, et al. (2009) A combined neuropsychological and brain imaging study of obstructive sleep apnea. J Sleep Res 18: 36–48.
  30. 30. Morrell MJ, McRobbie DW, Quest RA, Cummin AR, Ghiassi R, et al. (2003) Changes in brain morphology associated with obstructive sleep apnea. Sleep Med 4: 451–454.
  31. 31. Gozal E, Sachleben LR Jr, Rane MJ, Vega C, Gozal D (2005) Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms. Am J Physiol Cell Physiol 288: C535–542.
  32. 32. Xu W, Chi L, Row BW, Xu R, Ke Y, et al. (2004) Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 126: 313–323.
  33. 33. Veasey SC, Davis CW, Fenik P, Zhan G, Hsu YJ, et al. (2004) Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27: 194–201.
  34. 34. Pae EK, Chien P, Harper RM (2005) Intermittent hypoxia damages cerebellar cortex and deep nuclei. Neurosci Lett 375: 123–128.
  35. 35. Carpenter JS, Andrykowski MA (1998) Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 45: 5–13.
  36. 36. Beck A, Steer R, Brown G (1996) Manual for the Beck Depression Inventory-II. San Antonio, Texas: The Psychological Corporation.
  37. 37. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56: 893–897.
  38. 38. Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 67: 588–597.
  39. 39. Johns MW (1992) Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15: 376–381.
  40. 40. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: 175–191.
  41. 41. Arnau RC, Meagher MW, Norris MP, Bramson R (2001) Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol 20: 112–119.
  42. 42. Cross RL, Kumar R, Macey PM, Doering LV, Alger JR, et al. (2008) Neural alterations and depressive symptoms in obstructive sleep apnea patients. Sleep 31: 1103–1109.
  43. 43. Gottlieb DJ, Whitney CW, Bonekat WH, Iber C, James GD, et al. (1999) Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 159: 502–507.
  44. 44. Kumar R, Macey PM, Cross RL, Woo MA, Yan-Go FL, et al. (2009) Neural alterations associated with anxiety symptoms in obstructive sleep apnea syndrome. Depress Anxiety 26: 480–491.
  45. 45. Harper RM, Macey PM, Kumar R, Woo MA (2009) Neural Injury in Diabetic versus Non-Diabetic Obstructive Sleep Apnea Subjects: a Pilot Study. Sleep 32: A341.
  46. 46. Valladares EM, Macey PM, Kumar R, Woo MA, Cross RL, et al. (2007) Brain structural differences between REM-related and non-REM related obstructive sleep apnea. Soc Neurosci Abs. 230.234 p.
  47. 47. Macey PM, Woo MA, Kumar R, Harper RM (2008) Sex-related neural alterations in Obstructive Sleep Apnea. 7th Annual Research and Evidence-Based Practice Conference.
  48. 48. Lopez-Jimenez F, Somers VK (2006) Stress measures linking sleep apnea, hypertension and diabetes–AHI vs arousals vs hypoxemia. Sleep 29: 743–744.
  49. 49. Veasey SC (2006) Obstructive sleep apnea: re-evaluating our index of severity. Sleep Med 7: 5–6.
  50. 50. Hossain JL, Ahmad P, Reinish LW, Kayumov L, Hossain NK, et al. (2005) Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders? J Sleep Res 14: 245–253.
  51. 51. Mediano O, Barcelo A, de la Pena M, Gozal D, Agusti A, et al. (2007) Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J 30: 110–113.
  52. 52. Baguet JP, Hammer L, Levy P, Pierre H, Launois S, et al. (2005) The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128: 3407–3412.
  53. 53. Asano K, Takata Y, Usui Y, Shiina K, Hashimura Y, et al. (2009) New Index for Analysis of Polysomnography, ‘Integrated Area of Desaturation’, Is Associated with High Cardiovascular Risk in Patients with Mild to Moderate Obstructive Sleep Apnea. Respiration.
  54. 54. Iber C (2007) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specification. Westchester, IL: American Academy for Sleep medicine.
  55. 55. Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F (2002) Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 53: 737–740.
  56. 56. American Psychiatric Association., American Psychiatric Association. Task Force on DSM-IV (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. xxvii. Washington, DC: American Psychiatric Association.
  57. 57. (1994) Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition. Washington, DC: American Psychiatric Association.
  58. 58. Lamm J, Poeschel J, Smith S (2008) Obtaining a thorough sleep history and routinely screening for obstructive sleep apnea. J Am Acad Nurse Pract 20: 225–229.
  59. 59. Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320: 479–482.